Key Record Dates Identifier: NCT04133948
Brief Title: Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (DONIMI)

First Submitted : October 14, 2019
First Submitted that Met QC Criteria : October 17, 2019
First Posted : October 21, 2019

Last Update Submitted that Met QC Criteria : May 28, 2020
Last Update Posted : June 1, 2020